Search Orphan Drug Designations and Approvals
-
Generic Name: | sodium phenylbutyrate |
---|---|
Date Designated: | 08/19/2014 |
Orphan Designation: | Treatment of maple syrup urine disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Acer Therapeutics, Inc. One Gateway Center 300 Washington Street, Suite 351 Newton, Massachusetts 02458 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-